| Ditemukan 1888 dokumen dengan kata kunci 6393 |
Simpan CSV  |
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer†
|
|
|
|
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
|
|
|
|
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213
|
|
|
|
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II
|
|
|
|
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
|
|
|
|
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
|
|
|
|
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
|
|
|
|
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensivedisease- small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
|
|
|
|
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA
|
|
|
|
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.10, 15 May, 2013: p.719-725 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Hasil Pencarian
